Tuesday, May 14, 2013

Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl

Pfizer Inc. (PFE) issued its second recall of thyroid-disease treatment Levoxyl in recent weeks, this time because some tablets didn't meet potency standards.
Pfizer said Friday that Levoxyl is no longer available, and may not return to the market until mid-2014. Levoxyl is approved to treat hypothyroidism, a condition in which the thyroid gland doesn't produce enough hormones, and to prevent certain types of goite

Read more: http://www.foxbusiness.com/news/2013/05/10/pfizer-has-second-recall-thyroid-disorder-drug-levoxyl/#ixzz2TGqKQJFH